TRPV2 overexpression was associated with high relapse-free survival in triple-negative breast cancer, whereas the opposite was found in patients with esophageal squamous cell carcinoma or gastric cancer. This evidence concerns the gene TRPV2 and esophageal squamous cell carcinoma.